GKOS Glaukos Corp.
$161.59 -1.48%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.48%
YTD
+92.20%
P/E
—
P/B
9.88
ROE
-27.1%
Div yield
—
Beta
0.78
Market cap
$9.7B
RSI (14)
44
Next earnings
Oct 27, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$163.84
Close
$161.59
VWAP (n/a)
—
Day high
$164.00
Day low
$160.57
Volume
664K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Yahoo Finance · Sep 24
Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus
Yahoo Finance · Sep 23
Glaukos (GKOS) Stock Looks Fully Priced Against Its Sales Growth Story
Yahoo Finance · Sep 23
Glaukos (GKOS), Why Is It Back In The Spotlight?
Yahoo Finance · Sep 23
Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?
Yahoo Finance · Aug 28
Glaukos Announces Participation in Wells Fargo Healthcare Conference
Yahoo Finance · Aug 19
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 3, 2026 View → 10-Q Jul 29, 2026 View → 8-K Jul 29, 2026 View → 8-K Jun 3, 2026 View → 8-K May 4, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell GKOS. Try it in the Lab to size a position and see the risk.